Faliti, Caterina E. https://orcid.org/0000-0003-0487-1914
Van, Trinh T. P.
Anam, Fabliha A.
Cheedarla, Narayanaiah
Williams, M. Elliott https://orcid.org/0000-0001-8271-3394
Mishra, Ashish Kumar
Usman, Sabeena Y.
Woodruff, Matthew C.
Kraker, Geoff
Runnstrom, Martin C.
Kyu, Shuya
Sanz, Daniel
Ahmed, Hasan
Ghimire, Midushi
Morrison-Porter, Andrea
Quehl, Hannah
Haddad, Natalie S. https://orcid.org/0000-0002-1348-3094
Chen, Weirong
Cheedarla, Suneethamma
Neish, Andrew S.
Roback, John D.
Antia, Rustom https://orcid.org/0000-0001-7991-614X
Hom, Jennifer
Tipton, Christopher M.
Lindner, John M. https://orcid.org/0000-0002-4940-5354
Ghosn, Eliver https://orcid.org/0000-0001-7258-906X
Khurana, Surender https://orcid.org/0000-0002-0593-7965
Scharer, Christopher D. https://orcid.org/0000-0001-7716-8504
Khosroshahi, Arezou
Lee, F. Eun-Hyung https://orcid.org/0000-0002-6133-5942
Sanz, Ignacio https://orcid.org/0000-0003-4182-587X
Funding for this research was provided by:
Division of Intramural Research, National Institute of Allergy and Infectious Diseases (U54- 762 CA260563-01, U19-AI110483, U54- 762 CA260563-01)
U.S. Department of Health & Human Services | U.S. Food and Drug Administration (GCBER005, GCBER008)
Article History
Received: 26 September 2023
Accepted: 9 October 2024
First Online: 12 November 2024
Change Date: 2 December 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41590-024-02045-y
Competing interests
: F.E.-H.L. is the founder of MicroB-plex, Inc., and has research grants with Genentech. I.S. has research grants with Glaxo Smith Kline. The other authors declare no competing interests.